… Canada, told Medscape Medical News. The study was … ." Evaluating antidepressants beyond drug class may make … mianserin, mirtazapine, nefazodone, reboxetine, agomelatine, and viloxazine were … of a particular antidepressant treatment should be based …

… phase II trial of AXS-12 (reboxetine) in narcolepsy … developing novel drugs for the treatment of neuropsychiatric … stage biotechnology company focused on targeted drugs to … Verrica Pharmaceuticals Inc. (VRCA) Verrica Pharmaceuticals is a medical dermatology …

… Friday (Mar.8), AMAG Pharmaceuticals Inc. (AMAG) slipped nearly … is a biotechnology company developing next-generation medicines to … A phase II trial of AXS-12 (reboxetine) in narcolepsy … Cloth, approved for the treatment of primary axillary hyperhidrosis, …

… Drug Administration (FDA) for the treatment of narcolepsy. Topline results from the CONCERT trial … reboxetine) is a novel, oral, investigational medicine in development for the treatment … our ongoing clinical trials and anticipated clinical trials for our …

… trials: the placebo-controlled GEMINI Phase 3 trial … Drug Administration (FDA) Breakthrough Therapy designation for the treatment … inhibitor (reboxetine) being developed for the treatment of … next two months: BTIG Biotechnology Conference – August 12 …

… FDA Office of Orphan Drug Products to promising drugs … reboxetine) is a novel, oral, investigational medicine in development for the treatment … a Phase 3 trial in treatment resistant depression (TRD … ongoing clinical trials and anticipated clinical trials for …

… of Medicine. “Unfortunately, currently approved treatments are … open-label pilot trial, reboxetine treatment improved excessive daytime … investigational drug product not approved by the FDA. … ongoing clinical trials and anticipated clinical trials for …

… Food and Drug Administration (FDA), the European Medicines Agency ( … , Cerezyme, a treatment for Gaucher disease, … doctors and patients. Pharmaceutical corporations fund almost all pre-market clinical trials … of the antidepressant reboxetine versus placebo …

… different drug treatment options.  In a report published this week in the medical … the pills is the best course. However, this new study indicates antidepressants … ; reboxetine, sold as edronax; and trazodone, sold as Desyrel. A drug was …

… different drugs, with some antidepressants … duloxetine, fluvoxamine, reboxetine, trazodone, and venlafaxine … antidepressants should always be the first line of treatment.” “Medication … trials were funded by pharmaceutical companies, with overall 46 (9%) trials …